Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Mallinckrodt
Fish and Richardson
Johnson and Johnson
Dow
McKinsey
Daiichi Sankyo
Cipla
US Department of Justice

Generated: December 9, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TELAVANCIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Telavancin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00061633 Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) Completed Theravance Biopharma Antibiotics, Inc. Phase 2 Serious infections caused by resistant bacteria are becoming more of a medical problem throughout the world. One of the ways to deal with this problem is to develop new drugs that can control these bacteria. This study will measure how well TD-6424 (Telavancin) can control infections and whether this drug can be safely given to patients.
NCT00062647 Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia Completed Theravance Biopharma Antibiotics, Inc. Phase 2 The purpose of this study is to determine whether telavancin (TD-6424, ARBELIC) can be safety administered to patients with bloodstream infections and whether telavancin is effective in treating these infections.
NCT00077675 Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) Completed Theravance Biopharma Antibiotics, Inc. Phase 2 Serious infections caused by resistant bacteria are becoming more of a medical problem throughout the world. This study will measure how well TD-6424 (Telavancin) can control infections and whether the drug is safe to give to patients.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Telavancin Hydrochloride

Condition Name

Condition Name for Telavancin Hydrochloride
Intervention Trials
Infections, Gram-Positive Bacterial 2
Staphylococcal Skin Infection 2
Bacterial Pneumonia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Telavancin Hydrochloride
Intervention Trials
Communicable Diseases 5
Infection 5
Gram-Positive Bacterial Infections 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Telavancin Hydrochloride

Trials by Country

Trials by Country for Telavancin Hydrochloride
Location Trials
United States 18
Israel 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Telavancin Hydrochloride
Location Trials
California 4
Ohio 2
Connecticut 1
Illinois 1
Michigan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Telavancin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Telavancin Hydrochloride
Clinical Trial Phase Trials
Phase 4 3
Phase 3 5
Phase 2 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Telavancin Hydrochloride
Clinical Trial Phase Trials
Completed 11
Recruiting 3
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Telavancin Hydrochloride

Sponsor Name

Sponsor Name for Telavancin Hydrochloride
Sponsor Trials
Theravance Biopharma Antibiotics, Inc. 14
University of Michigan 1
M.D. Anderson Cancer Center 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Telavancin Hydrochloride
Sponsor Trials
Industry 15
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Moodys
McKesson
Cerilliant
Fish and Richardson
UBS
Queensland Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.